159 related articles for article (PubMed ID: 27161964)
1. Targeted Therapy for Metastatic Urothelial Cancer: A Work in Progress.
Plimack ER; Geynisman DM
J Clin Oncol; 2016 Jun; 34(18):2088-92. PubMed ID: 27161964
[TBL] [Abstract][Full Text] [Related]
2. Immune Checkpoint Blockade in Metastatic Urothelial Cancer.
Balar AV
J Clin Oncol; 2017 Jul; 35(19):2109-2112. PubMed ID: 28481707
[TBL] [Abstract][Full Text] [Related]
3. Decision Making in a Data-Poor Environment: Management of Brain Metastases From Testicular and Extragonadal Germ Cell Tumors.
Gilligan T
J Clin Oncol; 2016 Feb; 34(4):303-6. PubMed ID: 26668343
[TBL] [Abstract][Full Text] [Related]
4. Maximizing the Clinical Benefit of Anthracyclines in Addition to Taxanes in the Adjuvant Treatment of Early Breast Cancer.
Curigliano G; Criscitiello C
J Clin Oncol; 2017 Aug; 35(23):2600-2603. PubMed ID: 28661760
[TBL] [Abstract][Full Text] [Related]
5. Role of High-Dose Chemotherapy With Autologous Stem-Cell Rescue in Men With Previously Treated Germ Cell Tumors.
Pagliaro LC
J Clin Oncol; 2017 Apr; 35(10):1036-1040. PubMed ID: 27992270
[TBL] [Abstract][Full Text] [Related]
6. To treat or not to treat, that is the question: the role of bone-targeted therapy in metastatic prostate cancer.
Higano CS
J Clin Oncol; 2014 Apr; 32(11):1107-11. PubMed ID: 24590651
[TBL] [Abstract][Full Text] [Related]
7. Duration of Anti-Programmed Death-1 Therapy in Advanced Melanoma: How Much of a Good Thing Is Enough?
Khushalani NI
J Clin Oncol; 2018 Jun; 36(17):1649-1653. PubMed ID: 29389234
[TBL] [Abstract][Full Text] [Related]
8. Afatinib Activity in Platinum-Refractory Metastatic Urothelial Carcinoma in Patients With ERBB Alterations.
Choudhury NJ; Campanile A; Antic T; Yap KL; Fitzpatrick CA; Wade JL; Karrison T; Stadler WM; Nakamura Y; O'Donnell PH
J Clin Oncol; 2016 Jun; 34(18):2165-71. PubMed ID: 27044931
[TBL] [Abstract][Full Text] [Related]
9. Concurrent Chemotherapy and Radiation Therapy for Inoperable Locally Advanced Non-Small-Cell Lung Cancer.
Rosenzweig KE; Gomez JE
J Clin Oncol; 2017 Jan; 35(1):6-10. PubMed ID: 27870565
[TBL] [Abstract][Full Text] [Related]
10. Efficacy of post-nephroureterectomy cisplatin-based adjuvant chemotherapy for locally advanced upper tract urothelial carcinoma: a multi-institutional retrospective study.
Nakagawa T; Komemushi Y; Kawai T; Otsuka M; Miyakawa J; Uemura Y; Kanatani A; Taguchi S; Naito A; Suzuki M; Nishimatsu H; Hirano Y; Tanaka Y; Matsumoto A; Miyazaki H; Fujimura T; Fukuhara H; Kume H; Igawa Y; Homma Y
World J Urol; 2017 Oct; 35(10):1569-1575. PubMed ID: 28397000
[TBL] [Abstract][Full Text] [Related]
11. Pulmonary Infiltrates in a Patient With Advanced Melanoma.
Powell CA
J Clin Oncol; 2017 Mar; 35(7):705-708. PubMed ID: 28029320
[TBL] [Abstract][Full Text] [Related]
12. Remarkable response to fluorouracil, leucovorin, oxaliplatin, and irinotecan therapy in urothelial cancer of the renal pelvis: a case report.
Tsujino T; Takahara K; Matsunaga T; Yoshikawa Y; Takai T; Uchimoto T; Saito K; Tanda N; Hirano H; Nomi H; Ibuki N; Inamoto T; Azuma H
J Med Case Rep; 2017 Apr; 11(1):99. PubMed ID: 28391777
[TBL] [Abstract][Full Text] [Related]
13. Management of Stage II Germ Cell Tumors: Be Sure, Be Patient, Be Safe.
Kollmannsberger CK; Nappi L; Nichols C
J Clin Oncol; 2019 Aug; 37(22):1856-1862. PubMed ID: 31180818
[No Abstract] [Full Text] [Related]
14. Optimization of Risk Stratification in Localized Prostate Cancer.
Morgans AK
J Clin Oncol; 2018 Feb; 36(6):528-532. PubMed ID: 29303624
[TBL] [Abstract][Full Text] [Related]
15. Incorporating Androgen Deprivation With Dose-Escalated External-Beam Radiotherapy for Prostate Cancer.
Dosoretz AP; Yu JB
J Clin Oncol; 2016 May; 34(15):1718-22. PubMed ID: 27001587
[TBL] [Abstract][Full Text] [Related]
16. Hypothalamic-Pituitary Axis Dysfunction in Survivors of Childhood CNS Tumors: Importance of Systematic Follow-Up and Early Endocrine Consultation.
Chemaitilly W; Armstrong GT; Gajjar A; Hudson MM
J Clin Oncol; 2016 Dec; 34(36):4315-4319. PubMed ID: 27998231
[TBL] [Abstract][Full Text] [Related]
17. Epidermal growth factor receptor inhibitor with fluorouracil, leucovorin, and irinotecan as an alternative treatment for advanced upper tract urothelial carcinoma: a case report.
Lu YM; Chien TM; Lin CH; Chai CY; Huang CN
J Med Case Rep; 2016 Apr; 10():98. PubMed ID: 27091477
[TBL] [Abstract][Full Text] [Related]
18. Sequencing of Endocrine and Targeted Therapies in Hormone-Sensitive, Human Epidermal Growth Factor Receptor 2-Negative Advanced Breast Cancer.
Jackson EB; Chia SKL
J Clin Oncol; 2023 Aug; 41(24):3976-3983. PubMed ID: 37406271
[No Abstract] [Full Text] [Related]
19. Nomogram-based Prediction of Overall Survival in Patients with Metastatic Urothelial Carcinoma Receiving First-line Platinum-based Chemotherapy: Retrospective International Study of Invasive/Advanced Cancer of the Urothelium (RISC).
Necchi A; Sonpavde G; Lo Vullo S; Giardiello D; Bamias A; Crabb SJ; Harshman LC; Bellmunt J; De Giorgi U; Sternberg CN; Cerbone L; Ladoire S; Wong YN; Yu EY; Chowdhury S; Niegisch G; Srinivas S; Vaishampayan UN; Pal SK; Agarwal N; Alva A; Baniel J; Golshayan AR; Morales-Barrera R; Bowles DW; Milowsky MI; Theodore C; Berthold DR; Daugaard G; Sridhar SS; Powles T; Rosenberg JE; Galsky MD; Mariani L;
Eur Urol; 2017 Feb; 71(2):281-289. PubMed ID: 27726966
[TBL] [Abstract][Full Text] [Related]
20. Lymphedema Precautions: Time to Abandon Old Practices?
Ahn S; Port ER
J Clin Oncol; 2016 Mar; 34(7):655-8. PubMed ID: 26712226
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
